Literature DB >> 8955457

Familial hypercholesterolaemia: a pilot study of parents' and children's concerns.

S Tonstad1.   

Abstract

OBJECTIVE: To assess psychosocial concerns of families with familial hypercholesterolaemia.
METHODS: One-hundred-and-fifty-four single or pairs of parents of children age 6 - 16 years responded to a specifically designed questionnaire. One child from each family was interviewed.
RESULTS: Eleven percent of parents thought that their quality of life would have been better had they not known about the disease. None agreed totally that they wished the diagnosis had not been made. However, 20% reported familial conflicts and 8% that their child's emotional or social life had been adversely affected. Conflicts and adverse effects were associated with higher scores on the Child Behaviour Checklist (CBCL). Among the children, worry about cardiovascular disease (affirmed by 22%) was related to male sex and CBCL score. RELEVANCE: Most families do not indicate that they have experienced psychosocial problems due to familial hypercholesterolaemia. Parental ratings of the child's behavioural adjustment may identify vulnerable children.

Entities:  

Mesh:

Year:  1996        PMID: 8955457     DOI: 10.1111/j.1651-2227.1996.tb13916.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  9 in total

1.  Screening for familial hypercholesterolaemia. Effective, safe treatments and dna testing make screening attractive.

Authors:  J J Kastelein
Journal:  BMJ       Date:  2000-12-16

Review 2.  A rational approach to treating hypercholesterolaemia in children. Weighing the risks and benefits.

Authors:  S Tonstad
Journal:  Drug Saf       Date:  1997-05       Impact factor: 5.606

3.  Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.

Authors:  Steve E Humphries; Treena Cranston; Marcus Allen; Helen Middleton-Price; Maryam C Fernandez; Victoria Senior; Emma Hawe; Andrew Iversen; Richard Wray; Martin A Crook; Anthony S Wierzbicki
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

Review 4.  Should pediatric patients with hyperlipidemia receive drug therapy?

Authors:  Deepak Bhatnagar
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 5.  Choices for treatment of hyperlipidaemia.

Authors:  S Tonstad
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

6.  Treatment decision making for adolescents with familial hypercholesterolemia: Role of family history and past experiences.

Authors:  Thomas I Mackie; Lisa L Tse; Sarah D de Ferranti; Heather R Ryan; Laurel K Leslie
Journal:  J Clin Lipidol       Date:  2015-05-07       Impact factor: 4.766

Review 7.  The genetics of familial hypercholesterolemia and emerging therapies.

Authors:  Anja Vogt
Journal:  Appl Clin Genet       Date:  2015-01-28

8.  Parents' views of genetic testing and treatment of familial hypercholesterolemia in children: a qualitative study.

Authors:  Karen Forrest Keenan; Robert M Finnie; William G Simpson; Lorna McKee; John Dean; Zosia Miedzybrodzka
Journal:  J Community Genet       Date:  2018-06-14

9.  Enablers and barriers to treatment adherence in heterozygous familial hypercholesterolaemia: a qualitative evidence synthesis.

Authors:  Fiona J Kinnear; Elaine Wainwright; Rachel Perry; Fiona E Lithander; Graham Bayly; Alyson Huntley; Jennifer Cox; Julian Ph Shield; Aidan Searle
Journal:  BMJ Open       Date:  2019-07-31       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.